Intrinsic Value Partners, LLC Cyclerion Therapeutics, Inc. Transaction History

Intrinsic Value Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$0.43 - $0.9 $47 - $99	-110 Reduced 0.25%	43,105 $18,000
Q4 2022 Jan 12, 2023	SELL	$0.42 - $18.8 $2,142 - $95,880	-5,100 Reduced 10.56%	43,215 $28,000
Q2 2022 Jul 18, 2022	SELL	$0.47 - $1.29 $752 - $2,064	-1,600 Reduced 3.21%	48,315 $27,000
Q1 2022 Apr 28, 2022	SELL	$0.96 - $1.78 $720 - $1,335	-750 Reduced 1.48%	49,915 $55,000
Q4 2021 Feb 10, 2022	BUY	$1.56 - $2.99 $79,037 - $151,488	50,665 New	50,665 $87,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $153M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Intrinsic Value Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intrinsic Value Partners, LLC with notifications on news.